Brain Hemangioblastomas: Incidence and Management

Epidemiology and Classification

• VHL disease has an estimated incidence of approximately 1 in 36,000 people, with lifetime penetrance approaching 100% by age 75 1

Association with VHL Disease

• Up to 20% of VHL cases arise from de novo mutations without family history 3

Prognosis

• The National Institute of Health recommends lifelong surveillance for VHL patients due to ongoing risks of tumor development 3